首页>
外国专利>
Compound, pharmaceutical formulation, use of a compound, methods for prevention and / or treatment of conditions associated with glycogen synthase kinase-3 and disease prevention and / or treatment, and use of intermediates
Compound, pharmaceutical formulation, use of a compound, methods for prevention and / or treatment of conditions associated with glycogen synthase kinase-3 and disease prevention and / or treatment, and use of intermediates
"COMPOUND, PHARMACEUTICAL FORMULATION, USE OF A COMPOUND, METHODS FOR PREVENTION AND / OR TREATMENT OF CONDITIONS ASSOCIATED WITH GLYCOGEN SYNTASE KINASE-3 AND FOR PREVENTION AND / OR TREATMENT OF DISEASES, AND, USE OF INTERMEDIES." The present invention relates to novel compounds of formula (I) wherein: Z is N and X is CH or N; Y is CONR¬ 5¬; phenyl foot or a 5- or 6-membered heteroaromatic ring containing one or more heteroatoms selected from N, O or S; Q is phenyl or a 5- or 6-membered aromatic heterocyclic ring containing one or more nitrogen atoms; R is C 1-6 alkyl NR 10 10 R 11 or C 1-6 alkylazetidine; R¬ 10¬ is hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 0-6 alkyl C 3-6 cycloalkyl, C 0 alkylaryl -6-, C 0-61 alkyl heteroaryl or C 1-6 alkyl NR 8 8 R 9; R 11a is C 1-6 alkyl NR 8 8 R 9, C 0-6 alkyl C 3-6 cycloalkyl or C 0-6 alkylheterocycloalkyl; as a free base or a pharmaceutically acceptable salt, solvate or solvate of the salt thereof, a process for its preparation and novel intermediates used therein, pharmaceutical formulations containing said therapeutically active compounds and the use of said active compounds in therapy.
展开▼
机译:“化合物,药物制剂,化合物的使用,与糖原合酶激酶3相关的疾病的预防和/或治疗方法以及疾病的预防和/或治疗以及药物的使用。”本发明涉及式(I)的新化合物,其中:Z为N,X为CH或N;和Y为CONR 5-;苯基脚或含有一个或多个选自N,O或S的杂原子的5或6元杂芳族环; Q是苯基或含有一个或多个氮原子的5或6元芳族杂环; R为C 1-6烷基NR 10 10 R 11或C 1-6烷基氮杂环丁烷; R 10是氢,C 1-6烷基,C 2-6烯基,C 2-6炔基,C 0-6烷基C 3-6环烷基,C 0烷基芳基-6,C 0-61烷基杂芳基或C 1-6烷基NR 8 8 R 9; R 11a为C 1-6烷基NR 8 8 R 9,C 0-6烷基,C 3-6环烷基或C 0-6烷基杂环烷基;作为游离碱或其盐的药学上可接受的盐,溶剂化物或溶剂化物,其制备方法和其中使用的新型中间体,含有所述治疗活性化合物的药物制剂以及所述活性化合物在治疗中的用途。
展开▼